Cargando…

Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction

AIM/OBJECTIVE: To see the levels of serum MDA in type 2 DM with MI. As Serum malonaldeyhde (MDA), a stable end product of lipid per oxidation produced by interaction of free radicals with membrane phospholipids, was estimated. MATERIALS AND METHODS: 30 type 2 diabetes mellitus cases with myocardial...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahreen, Rashida, Mohsin, M., Nasreen, Zahida, Siraj, M., Ishaq, M.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859285/
https://www.ncbi.nlm.nih.gov/pubmed/20431807
http://dx.doi.org/10.4103/0973-3930.60006
_version_ 1782180493593149440
author Mahreen, Rashida
Mohsin, M.
Nasreen, Zahida
Siraj, M.
Ishaq, M.
author_facet Mahreen, Rashida
Mohsin, M.
Nasreen, Zahida
Siraj, M.
Ishaq, M.
author_sort Mahreen, Rashida
collection PubMed
description AIM/OBJECTIVE: To see the levels of serum MDA in type 2 DM with MI. As Serum malonaldeyhde (MDA), a stable end product of lipid per oxidation produced by interaction of free radicals with membrane phospholipids, was estimated. MATERIALS AND METHODS: 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of Type 2 diabetics without complications are enrolled. Thirty healthy subjects served as controls. Quantitative estimation of serum MDA levels were carried out in all the three groups, along with fasting blood glucose and total serum cholesterol. RESULTS: It was found that serum MDA levels were significantly higher in both diabetic groups compare to the controls (P<0.01). Within the diabetic group, the serum MDA levels were significantly high in patients with myocardial infarction (P<0.01). CONCLUSION: The possible reason for significantly high serum MDA levels in cases of diabetic with myocardial infarction is due to tissue damage caused by myocardial infarction resulting in increased rate of production of free radicals as assessed by lipid per oxidation.
format Text
id pubmed-2859285
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28592852010-04-29 Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction Mahreen, Rashida Mohsin, M. Nasreen, Zahida Siraj, M. Ishaq, M. Int J Diabetes Dev Ctries Original Article AIM/OBJECTIVE: To see the levels of serum MDA in type 2 DM with MI. As Serum malonaldeyhde (MDA), a stable end product of lipid per oxidation produced by interaction of free radicals with membrane phospholipids, was estimated. MATERIALS AND METHODS: 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of Type 2 diabetics without complications are enrolled. Thirty healthy subjects served as controls. Quantitative estimation of serum MDA levels were carried out in all the three groups, along with fasting blood glucose and total serum cholesterol. RESULTS: It was found that serum MDA levels were significantly higher in both diabetic groups compare to the controls (P<0.01). Within the diabetic group, the serum MDA levels were significantly high in patients with myocardial infarction (P<0.01). CONCLUSION: The possible reason for significantly high serum MDA levels in cases of diabetic with myocardial infarction is due to tissue damage caused by myocardial infarction resulting in increased rate of production of free radicals as assessed by lipid per oxidation. Medknow Publications 2010 /pmc/articles/PMC2859285/ /pubmed/20431807 http://dx.doi.org/10.4103/0973-3930.60006 Text en © International Journal of Diabetes in Developing Countries http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mahreen, Rashida
Mohsin, M.
Nasreen, Zahida
Siraj, M.
Ishaq, M.
Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title_full Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title_fullStr Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title_full_unstemmed Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title_short Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
title_sort significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859285/
https://www.ncbi.nlm.nih.gov/pubmed/20431807
http://dx.doi.org/10.4103/0973-3930.60006
work_keys_str_mv AT mahreenrashida significantlyincreasedlevelsofserummalonaldehydeintype2diabeticswithmyocardialinfarction
AT mohsinm significantlyincreasedlevelsofserummalonaldehydeintype2diabeticswithmyocardialinfarction
AT nasreenzahida significantlyincreasedlevelsofserummalonaldehydeintype2diabeticswithmyocardialinfarction
AT sirajm significantlyincreasedlevelsofserummalonaldehydeintype2diabeticswithmyocardialinfarction
AT ishaqm significantlyincreasedlevelsofserummalonaldehydeintype2diabeticswithmyocardialinfarction